Abstract
AMOXAPINE is a new antidepressant approved for marketing in the United States just over a year ago. It is structurally similar to both loxapine succinate and imipramine hydrochloride, and its mechanism of action is through blocking the reuptake of norepinephrine primarily and serotonin secondarily as well as having a dopamine-receptor blocking effect. It has become one of the most popular antidepressants in use today, largely because of its low incidence of side effects and toxic reactions and its possible earlier onset of action.1-5Our recent experience with a patient who ingested excessive amounts of this drug has alerted us to a yet unreported and potentially lethal complication of amoxapine overdose. Report of a Case A 17-year-old girl was transferred to Vanderbilt University Medical Center, Nashville, Tenn, from an outlying hospital after ingesting at least 4 g of amoxapine (approximately 60 mg/kg) in an impulsive suicide gesture. She had been
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
